Technology | Quality Assurance (QA) | April 27, 2016

IBA Releases Dolphin Online Ready Patient QA and Monitoring System

System enables more efficient pre-treatment patient QA, with future online treatment monitoring for safer delivery of each treatment fraction enabled after linac interoperability confirmation

IBA, Dolphin ONline Read Patient QA and Monitoring, quality assurance

April 27, 2016 — IBA (Ion Beam Applications S.A.) announced the release of Dolphin Online Ready Patient QA and Monitoring. Dolphin enhances workflows in pre-treatment QA (quality assurance), while being mindful of future online treatment monitoring.

To achieve added efficiency, Dolphin offers a “plug-and-play” design that enables significantly faster pre-treatment QA. Dolphin only requires two minutes to set up and wirelessly transmits the measured detector response to the Dolphin workstation. Additionally, the new automatic verification software QuickCheck saves valuable time by providing instant analysis of the Dolphin measurements and giving an “OK” message for the tests successfully passed.

This design ensures that Dolphin will enable future online treatment monitoring by measuring the actual delivery during patient treatment and by automatic QuickCheck verification immediately after each fraction, seamlessly integrating into the therapist’s workflow.

“The Dolphin will offer the possibility for online verification of complex dose delivery techniques such as IMRT [intensity modulated radiation therapy] or VMAT [volumetric modulated arc therapy] with the patient already in treatment position. Used for multiple treatment fractions the system even offers inherently a new possibility for cumulative delivered dose tracking,” said Dr. Hansjoerg Wertz, Dept. of Radiation Oncology, University Medical Centre Mannheim, University of Heidelberg, Mannheim, Germany in the name of the whole “Dolphin team” at UMM. “The novel online QA system contributes to reduce extra pre-treatment QA time to a minimum while at the same time increasing patient safety and preventing severe accidents due to the immediate detection of dose delivery errors. Based on our intensive initial experiences, we are planning to implement Dolphin into our clinical routine workflow for our patient verification during treatment as soon as possible. This gives us the ultimate confidence in treating our patients safely.”

Dolphin offers not only a simple consistency check but is coupled with the advanced analysis of each measured dose, and in turn, offers a complete patient QA solution. The clinical relevance of the dose discrepancies is comprehensively determined with DVH and in 3-D patient anatomy using sophisticated TPS-Class verification software. Following this verification process, the clinical team can determine whether re-planning or plan adaptation is needed or machine-specific parameters can be verified.

Dolphin is also designed for future applications, such as Machine QA and Adaptive-QA using cone beam computed tomography (CBCT) and dose of the day. The versatility of Dolphin makes it the universal detector for integrating future real time measurements into IBA’s myQA global QA platform for several key dosimetry applications, from Patient QA to Machine QA and more.

For more information: www.iba-worldwide.com

Related Content

Videos | Radiation Therapy | February 20, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
Study Unveils Blueprint for Treating Radiation-Resistant Brain Tumor

NIH-funded researchers showed how gliomas may be treated with radiation and drugs that block DNA repair. Image courtesy of Castro lab, Michigan Medicine, Ann Arbor

 

News | Radiation Therapy | February 19, 2019
February 19, 2019 — Researchers at the University of Michigan recently searched for new brain tumor treatments by exp
Videos | Radiation Therapy | February 15, 2019
ITN Associate Editor Jeff Zagoudis speaks with Vinai Gondi, M.D., director of research and CNS neuro-oncology at the
New Targeted Therapy for Recurrent Brain Tumors Implanted for First Time
News | Radiation Therapy | February 15, 2019
University of Minnesota Health (M Health) is the first in the United States to begin offering GammaTile Therapy, a new...
Canon Adds Radiation Therapy Package to Aquilion Prime, Lightning CT Systems
News | Computed Tomography (CT) | February 11, 2019
In the patient-centric world of radiation oncology, it is critical that computed tomography (CT) simulation is...
Elekta Unity MR-Linac Earns FDA Clearance
Technology | Image Guided Radiation Therapy (IGRT) | February 07, 2019
The Elekta Unity magnetic resonance radiation therapy (MR/RT) system recently received 510(k) premarket notification...
University of Oklahoma Cancer Center Begins First Proton Therapy Treatments
News | Proton Therapy | February 01, 2019
Home to the largest and most comprehensive radiation therapy program in Oklahoma, the Stephenson Cancer Center at OU (...
Stereotactic Radiotherapy Improves Long-Term Survival in Stage-IV Cancers
News | Stereotactic Body Radiation Therapy (SBRT) | January 31, 2019
The first report from a phase II, multi-center clinical trial indicates stereotactic radiation can extend long-term...
Philips Collaborates With MIM Software on Radiation Therapy Treatment Planning
News | Treatment Planning | January 31, 2019
January 31, 2019 — Philips announced a collaboration with imaging solutions provider MIM Software Inc.
Videos | Lung Cancer | January 29, 2019
Gregory Videtic, M.D., staff physician in radiation oncology at the Cleveland Clinic, and David Johnstone, M.D., prof